|
C12ORF5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.588500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.215610E-02 |
| Normal-vs-Stage2 |
1.281790E-01 |
| Normal-vs-Stage3 |
4.515700E-02 |
| Normal-vs-Stage4 |
7.787600E-01 |
| Stage1-vs-Stage2 |
5.707400E-01 |
| Stage1-vs-Stage3 |
5.649800E-01 |
| Stage1-vs-Stage4 |
4.776200E-01 |
| Stage2-vs-Stage3 |
9.507400E-01 |
| Stage2-vs-Stage4 |
3.886800E-01 |
| Stage3-vs-Stage4 |
3.220600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.082580E-03 |
| Normal-vs-AfricanAmerican |
1.931620E-02 |
| Normal-vs-Asian |
2.044400E-01 |
| Caucasian-vs-AfricanAmerican |
6.013400E-01 |
| Caucasian-vs-Asian |
4.506600E-01 |
| AfricanAmerican-vs-Asian |
7.299400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.776320E-03 |
| Normal-vs-Female |
3.764100E-04 |
| Male-vs-Female |
9.074000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.220100E-02 |
| Normal-vs-Extreme_Weight |
3.562000E-02 |
| Normal-vs-Obese |
2.741900E-02 |
| Normal-vs-Extreme_Obese |
9.264000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.634800E-01 |
| Normal_Weight-vs-Obese |
4.973800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.012400E-01 |
| Extreme_Weight-vs-Obese |
5.473000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.637600E-01 |
| Obese-vs-Extreme_Obese |
3.389800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.957090E-03 |
| Normal-vs-Age(41-60Yrs) |
2.985300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.424800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.645400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.624000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.815600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.655500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.595600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.877800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.368000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.788400E-04 |
| Normal-VS-Type2 PRCC |
5.546400E-02 |
| Normal-VS-KIRP CIMP |
2.280500E-03 |
| Normal-VS-Unclassified PRCC |
1.201180E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.340400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.124000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.712300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.176200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.058180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.898400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.590830E-01 |
| Normal-vs-N1 |
7.577200E-03 |
| Normal-vs-N2 |
8.334200E-01 |
| N0-vs-N1 |
6.253600E-02 |
| N0-vs-N2 |
8.800000E-01 |
| N1-vs-N2 |
3.824800E-01 |
|
|
